Hadlima
Active Ingredient(s): Adalimumab-bwwdFDA Approved: * July 23, 2019
Pharm Company: * SAMSUNG BIOEPIS CO LTD
Category: Immunosuppressive
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[5][6][7] It is administered by injection under the skin.[5] Common side effects include upper respiratory tract infections, pain at the site o... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.